Global health-tech venture Eckuity announced today that it has invested in Sonrai Analytics, a commercial-stage data management and bioinformatics company.
Staying ahead of the competition in the pharma/biotech industry is all about how you use your own data.
Pharma/biotech companies are sitting on billions of dollars of unrealized value buried deep within the petabyte piles of disorganized data they already own.
Sonrai’s platform empowers researchers to quickly integrate, process, and visualize complex, disparate, and siled datasets, reducing timelines and generating valuable insights. Importantly, the platform ensures data manipulation remains validated and compliant with the law.
“We have rapidly improved our products and services by understanding our customers’ challenges and meeting their expectations. This additional capital further strengthens our commercial endeavors and allows us to diversify our market segments,” said Dr. Darragh McArt, Founder and Chief Executive Officer of Sonrai Analytics. “We are excited to have Eckuity join our team as we accelerate opportunities in the US, and offer advice and support as we continue to develop the business.”
“Research companies and organizations are already sitting on a treasure trove of data if only they could access it in a way that was easy to see and easy to integrate,” said Mark Goldstone, partner at Eckuity. “Sonrai integrates data visualization and predictive analytics into workflows to accelerate organizational processes, improve performance and unlock business value. We are very excited about the impact Sonrai will have on the market.”